Navigation Links
Cambridge Healthtech Institute to Host Its Second Annual Collaborative Innovation in Biomedicine Conference
Date:4/30/2010

Strategies and Best Practices for Pre-Competitive Sharing of Data, Results and Costs

Needham, MA (PRWEB) April 30, 2010 -- Cambridge Healthtech Institute will host its second annual Collaborative Innovation in Biomedicine conference on June 14-16, 2010 in Philadelphia, PA. The biomedical industry is under enormous pressure to produce faster results, while also finding ways to reduce costs. Examples abound in one industry after another of how researchers have gained tremendous advantages by collaborating on pre-competitive efforts, but such efforts have been limited in biomedical research, where researchers often find it difficult to openly share data within their own organization, much less with competitors. This conference aims to bring together a number of experts with practical experience in organizing, managing, funding, and getting results from pre-competitive collaborative projects. Speakers will talk from first-hand experience about what works and what doesn't as the program explores the most important new models, key issues, challenges and best practices of Collaborative Innovation in Biomedicine.

"Given the number of challenges that the industry is facing," says Phillips Kuhl, President of Cambridge Healthtech Institute, "There is clearly a need for new models and approaches. A key goal of the program is to provide attendees with a number of key strategies for identifying when and how collaborative innovation can and should be encouraged, as well as when such efforts are less likely to produce useful results."

The conference program will deal with topics such as case studies of successful consortia and collaborations; strategies for dealing with the challenge of shared intellectual property; strategies and technology for facilitating data sharing; novel approaches for identifying collaborative information and partners; collaborative development and evaluation of new technology and software; and more. The conference will feature speakers with first-hand experience in setting up and running successful consortia.

Featured speakers include a number of representatives from large pharma: Jackie Hunter, Ph.D., Senior Vice President, Science Environment Development, GlaxoSmithKline; Robin Spencer, Ph.D., Senior Fellow, Research Centers of Emphasis, Pfizer, Inc.; Stefan J. Platz, Ph.D., Head, Toxicology & Pathology, F. Hoffman-LaRoche Ltd.; David Cook, Ph.D., Global Safety Assessment, AstraZeneca Pharmaceuticals; Bryn Williams-Jones, Ph.D., Associate Research Fellow; Head, eBiology, Pfizer; and Ramesh Durvasula, Ph.D., Director, Chemistry Informatics, Research Informatics & Automation, Bristol-Myers Squibb.

In addition, case studies of emerging consortia-based models and best practices will be presented by representatives from consortia, not-for-profit and academics, as well as executives from technology/biotechnology companies: Eric Thompson, Ph.D., Assistant Director, Predictive Safety Testing Consortium, Critical Path Institute; Robert Porter-Lynch, Ph.D., CEO, The Warren Group; Managing Partner, System of Trust, LLC; Les Jordan, Chief Technology Strategist, Microsoft Life Sciences; Sean Ekins, Ph.D., Collaborations Director, Research & Development, Collaborative Drug Discovery; Jean-Robert Ioset, Professor, Project Coordinator, Research & Development, Drugs for Neglected Diseases initiative (DNDi); Max Fehlmann, Ph.D., President & CEO, Quebec Consortium of Drug Discovery; Mariana Guergova-Kuras, Ph.D., Director of Research, Biosystems International; Shawnmarie Mayrand-Chung, Ph.D., NIH Director for The Biomarkers Consortium & Senior Advisor to The Biomarkers Consortium; Syril D. Pettit, Ph.D., MEM, Associate Director, HESI, ILSI; John Overington, Ph.D., Team Leader, Chemogenomics, EMBL-EBI, Wellcome Trust Genome Campus; and Sandor Szalma, Ph.D., Senior Research Fellow, Research & Development Informatics, Centocor R&D, Inc.

The Collaborative Innovation in Biomedicine conference is immediately followed by CHI's inaugural Encouraging Development of Therapeutics for Neglected Diseases conference being held June 16-17, 2010. Cambridge Healthtech Institute offers package pricing to attendees interested in participating in both conferences.

Please visit www.healthtech.com/cbi for more information.

About Cambridge Healthtech Institute (CHI)
Founded in 1992, Cambridge Healthtech Institute (CHI) (www.chicorporate.com) is the industry leader offering the preeminent source of information to the leading researchers and business experts from top pharmaceutical, biotech, and academic organizations. Delivering an assortment of resources such as events, reports, publications and eNewsletters, CHI's portfolio of products include Cambridge Healthtech Institute Conferences, Barnett International, Insight Pharma Reports, Cambridge Marketing Consultants, Cambridge Meeting Planners, and Cambridge Healthtech Media Group.

Contact: Kaushik Chaudhuri
Cambridge Healthtech Institute
(781) 972-5419
kchaudhuri(at)healthtech(dot)com

###

Read the full story at http://www.prweb.com/releases/2010/04/prweb3947754.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Christine P. Carrington, President of NurseTesting Creative Solutions, Inducted into Cambridge Who's Who
2. Cambridge Healthtech Announces Its Inaugural Encouraging Development of Therapeutics for Neglected Diseases Conference
3. Rush Limbaugh & Michael Steele Join Tea Party Support & Social Security Institute-Demand GOP Senate Stop ObamaCare by Any Means Possible
4. MRI Partners with Natural Marketing Institute
5. Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting
6. Institute for Healthcare Advancement's Ninth Annual Health Literacy Conference Set for May 6-7, 2010 in Irvine, Calif.
7. Biomedical Industry Jobs Critical to California's Economic Recovery, Finds California Healthcare Institute and PricewaterhouseCoopers
8. The Colorado Institute for Drug, Device and Diagnostic Development Launches With a Statewide Call for Proposals From Life Science Technologies in Need of Funding and Active Management
9. Karmanos Cancer Institute in Detroit Names Gerold Bepler, M.D., Ph.D., as CEO
10. NASA selects DNA Medicine Institutes Nanoscale Diagnostics Technology for Phase II SBIR
11. The Andrews Institute and Reebok Join Partner Roster for USA Football's “Team USA vs. The World” Game, Presented By Riddell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... 26, 2017 , ... IndustryArchive.Org . is announcing a new way for ... will now only pay for B.A.N.T. quality sales leads based on the Sellers decision ... the new reality that B2B buyers are controlling the sales process via the Internet ...
(Date:2/26/2017)... , ... February 26, 2017 , ... ... disease (PD) in persons with a specific LRRK2 mutation, according to a study ... Previous studies have provided evidence of a link between pesticides and incidence of ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official ... (ILTM) show in Cannes (France), XO Private has initiated a second print-run of its ... measures almost a metre across when open, weighs in at more than six kilos, ...
(Date:2/24/2017)... ... 24, 2017 , ... The Smart Machine Age is here, and it’s disrupting ... percent of all jobs in the United States may be taken over by technology ... the aggressive know-it-all who steamrolls over colleagues is drawing to a close. Success will ...
(Date:2/24/2017)... Australia (PRWEB) , ... February 24, 2017 , ... The ... AU) offers Erik Schanssema ’s true account of his paramedic experiences. Schanssema describes ... stress disorder and his attempts to overcome them. , Schanssema, initially unsure of ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... REDWOOD CITY, Calif., Feb. 23, 2017 Nevro Corp. ... innovative evidence-based solutions for the treatment of chronic pain, today ... ended December 31, 2016. 2016 Accomplishment & ... the full year 2016, an increase of 228% as reported, ... million for 2016, an increase of 612% over the prior ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
(Date:2/23/2017)... , Feb. 23, 2017 Regulus ... the discovery and development of innovative medicines targeting microRNAs, ... year 2016 financial results on Thursday, March 2, 2017 ... a conference call and webcast on March 2, 2017 ... and full year 2016 financial results and provide a ...
Breaking Medicine Technology: